Prophylactic surgery for multiple endocrine neoplasia type IIa after genetic diagnosis: Is parathyroid transplantation indicated?

World Journal of Surgery

Volumn 20, Issue 7, 1996, Pages 814-821

  Decker, Ruth A ^a,b   Geiger, James D ^a   Cox, Charles E ^a   Mackovjak, Marilyn ^a   Sarkar, Minakshi ^a   Peacock, Michael L ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; DNA;

CALCIUM BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; DENATURING GRADIENT GEL ELECTROPHORESIS; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; PARATHYROID TRANSPLANTATION; PARATHYROIDECTOMY; POLYMERASE CHAIN REACTION; PROPHYLAXIS; PROTO ONCOGENE; SIPPLE SYNDROME; THYROID HYPERPLASIA; THYROIDECTOMY;

CALCIUM; CARCINOMA, MEDULLARY; CHILD; CHILD, PRESCHOOL; CODON; FEMALE; GERM-LINE MUTATION; HUMANS; HYPERPARATHYROIDISM; HYPERPLASIA; INFANT; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; PARATHYROID GLANDS; PARATHYROID HORMONE; PARATHYROIDECTOMY; PROTO-ONCOGENES; RECEPTOR PROTEIN-TYROSINE KINASES; RISK FACTORS; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY; TRANSPLANTATION, AUTOLOGOUS;

EID: 0029810636     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002689900124     Document Type: Conference Paper

References (27)

1. Mulligan, L.M., Kwok, J.B.J., Healey, C.S., et al.: Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2a. Nature 363:458, 1993
2. Donis-Keller, H., Dou, S., Chi, D., et al.: Mutations in the RET proto-oncogene are associated with MEN 2a and FMTC. Hum. Mol. Genet. 2:851, 1993
3. Decker, R.: Long-term follow-up of a large North American with multiple endocrine neoplasia type 2a. Surgery 112:1066, 1992
4. Schimke, R.N.: Genetic aspects of multiple endocrine neoplasia. Annu. Rev. Med. 35:25, 1984
5. Komminoth, P., Kunz, E.K., Matias-Guiu, X., et al.: Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas. Cancer 76:479, 1995
6. Schuffenecker, I., Billaud, M., Calender, A., et al.: RET protooncogene mutations in French MEN 2a and FMTC families. Hum. Mol. Genet. 3:1939, 1994
7. Xue, F., Hong, Y., Maurer, L., et al.: Germline RET mutations in MEN 2a and FMTC and their detection by simple DNA diagnostic tests. Hum. Mol. Genet. 3:635, 1994
8. Bolino, A., Schuffenecker, I., Luo, Y., et al.: RET mutations in exons 13 and 14 of FMTC patients. Oncogene 10:2415, 1995
9. Eng, C., Smith, D.P., Mulligan, L.M., et al.: A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. Oncogene 10:509, 1995
10. Mulligan, L., Eng, C., Healey, C., et al.: Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2a and FMTC. Nat. Genet. 6:70, 1994
11. Decker, R.A., Peacock, M.L., Borst, M.J., Sweet, J.D., Thompson, N.W.: Progress in genetic screening of multiple endocrine neoplasia type 2a: is calcitonin testing obsolete? Surgery 118:257, 1995
12. Wells, S.A., Chi, D.D., Toshima, K., et al.: Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2a. Ann. Surg. 220:237, 1994
13. Gagel, R.F., Tashjian, A.H., Cummings, T., et al.: The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. N. Engl. J. Med. 318:478, 1988
14. Thakker, R.V., Ponder, B.A.J.: Multiple endocrine neoplasia. Clinical Endocrinology and Metabolism (Vol. 2), M.C. Sheppard, editor. Baillière Tindall, London, 1988, p. 1031
15. Decker, R.A.: Expression of papillary thyroid carcinoma in multiple endocrine neoplasia type 2a. Surgery 114:1059, 1993
16. Peacock, M.L., Borst, M.J., Sweet, J.D., Decker, R.A.: Detection of RET mutations in multiple endocrine neoplasia type 2a and familial medullary thyroid carcinoma by denaturing gradient gel electrophoresis. Hum. Mutat. 7:100-104, 1996
17. Lerman, L., Silverstein, K.: Computational simulation of DNA melting and its application to denaturing gradient gel electrophoresis. Methods Enzymol. 155:482, 1987
18. Itoh, F., Ishizaka, Y., Tahira, T., et al.: Identification and analysis of the ret proto-oncogene promoter region in neuroblastoma cell lines and medullary thyroid carcinoma from MEN 2a patients. Oncogene 7:1201, 1992
19. Kwok, J.B.J., Gardner, E., Warner, J.P., Ponder, B.A.J., Mulligan, L.M.: Structural analysis of the human RET proto-oncogene using exon trapping. Oncogene 8:2575, 1993
20. Fabien, N., Paulin, C., Santoro, M., et al.: The RET proto-oncogene is expressed in normal human parafollicular thyroid cells. Int. J. Oncol. 4:623, 1994
21. Santoro, M., Rosati, R., Grieco, M., et al.: The RET proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene 5:1595, 1990
22. Nakamura, T., Ishizaka, Y., Nagao, H.M., Ishikawa, T.: Expression of the RET proto-oncogene product in human normal and neoplastic tissues of neural crest origin. J. Pathol. 172:255, 1994
23. Smith, D.P., Eng, C., Ponder, B.A.J.: Mutations of the RET protooncogene in the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease. J. Cell Sci. 18:43, 1994
24. Telander, R.L., Zimmerman, D., Sizemore, G.W., van Heerden, J.A., Grant, C.S.: Medullary thyroid carcinoma: results of early detection and surgery. Arch. Surg. 124:841, 1989
25. Lips, C.J.M., Landsvater, R.M., Hoppener, J., et al.: Clinical screening as compared with DNA analysis in families with multiple endocrine neopalsia type 2a. N. Engl. J. Med. 331:828, 1994
26. Cotton, R.G.H., Malcolm, A.D.B.: Mutation detection. Nature 353: 582, 1991
27. Dianzani, I., Camaschella, C., Ponzone, A., Cotton, R.G.H.: Dilemmas and progress in mutation detection. TIG 9: 1993.